This website is intended for healthcare professionals only
Specialities

Specialities

Alzheimer's Disease and Dementia
Brain Trauma
COVID-19
Epilepsy
Headache Disorders
Neurodegenerative Diseases
Movement Disorders
Multiple Sclerosis
Neuroimmunology
Neurological Oncology
Neurometabolic Disease
Neuromuscular Diseases
Neuropathic Pain
Stroke
Neurosurgery
Pediatric Neurology
Parkinson's Disease
Psychiatric Disorders
Rare Diseases
Sleep Disorders
Central Nervous Disorders
Neuroradiology
Search

Trending Topic

Conceptual design with brain and red abstract background. Horizontal banner.
15 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Mechanical thrombectomy: Evidence basis and future directions

Abdelmageet Hassan, Sumanjit Gill

Both intracerebral hemorrhage and ischemic stroke continue to be the leading causes of disability and the second leading causes of death worldwide.1,2 The burden is largest in low- and middle-income countries, which have seen rapid recent population growth. Large vessel occlusion (LVO – internal carotids, vertebrals and the proximal branches of the circle of Willis) accounts for 20% of all acute ischemic strokes (AISs) […]

touchREVIEWS in Neurology. 2026;22(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

3 Results Found for “metabolomics”

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Huntingtons disease cell structure abnormal protein buildup illustration neurodegenerative genetic disorder visualization
Mark CompleteCompleted
BookmarkBookmarked

Genetic, Proteomic and Metabolic Biomarkers for Predicting and Monitoring Huntington’s Disease Progression: A Systematic Review

Gloria Ibis Tirado Romero, Ana María Jiménez Echavarría, Laura Rocío Orrego-Agudelo

Huntington’s disease (HD) is a fatal, autosomal-dominant, neurodegenerative disorder caused by a cytosine–adenine–guanine (CAG) trinucleotide repeat expansion in the huntingtin (HTT) gene, located on chromosome 4p16.3. When this repeat exceeds 36 units, it leads to the synthesis of ...

touchREVIEWS in Neurology. 2025;21(1):51-62
Mark CompleteCompleted
BookmarkBookmarked

Data Sharing in Alzheimer’s Disease Research

  There has been an explosion of data in the field of Alzheimer’s disease (AD), not only from clinical studies but also studies that generate hypotheses and opportunities that may accelerate drug development. In order to make optimal use ...

US Neurology. 2018;14(2):68–70 DOI: https://doi.org/10.17925/USN.2018.14.2.68
No Featured Image
Mark CompleteCompleted
BookmarkBookmarked

Blood Biomarkers for Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial and heterogeneous disease in both its clinical and histopathological appearance. In more than 99% of cases the cause of the disease is not understood. Independent of its cause, AD is clinically characterised by a ...

European Neurological Review, 2008;3(2):28-31 DOI: http://doi.org/10.17925/ENR.2008.03.02.28

Latest articles videos and clinical updates - straight to your inbox

Close Popup